# FLAVOXATE HYDROCHLORIDE

NDC: 0574-0115
Generic name: FLAVOXATE HYDROCHLORIDE
Labeler / Manufacturer: Padagis US LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20041222
Marketing ended: 20261231
FDA application: ANDA076831

## Active ingredients

- FLAVOXATE HYDROCHLORIDE: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0574-0115"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0574-0115
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a9c44c4b-5b3c-45bf-9bc9-ce858e3d06c5